Metro US is proud to unveil the re-launch of ZipTrials.us, its unique clinical trial registration and medical news site. Credit: ColourBox
Metro US is proud to unveil the relaunch of ZipTrials.us, its unique clinical trial registration and medical news site. Revamped with a fresh look, increased functionality and more targeted news coverage, the new ZipTrials seamlessly connects interested participants with medical research studies – in fact, it only takes three clicks.
ZipTrials visitors can now enjoy optimized search functionality, which makes finding and registering for a clinical trial easier than ever. And with access to the latest health and wellness news, users can keep up with top trending health stories without missing a beat.
Since its inception in 2011, ZipTrials has grown significantly and is actively widening its reach to new markets across the country. Last year alone, the site generated over 3,000 leads to more than 300 clinical trials with an impressive click-through rate of 3.39 percent. ZipTrials consistently delivers unparalleled response rates for its clients and offers comprehensive clinical trial solutions. This includes utilizing our print markets and partnerships to recruit trial participants. Our unique advertising package also increases the overall return on investment for our clients’ print ads.
“We are hugely proud to deliver effective and affordable solutions to serve the medical research community through ZipTrials,” said Yggers Mortensen, Publisher and CEO of Metro US.
“Bringing ZipTrials’ enhanced user experience to the next level is the natural next step in our national expansion plan, and I am personally looking forward to expanding ZipTrials to more markets later this year,” Mortensen added.
ZipTrials is part of Metro US, the nation’s most read free daily newspaper. With a proudly metropolitan tone and urban style, Metro is written and designed for young, ambitious professionals and features a mix of hard-hitting news and colorful features. Metro reaches 1.2 million readers in New York, Boston and Philadelphia.
